Norman Biotech was identified as the "National SRDI Little Giants"

According to the identification of the Ministry of Industry and Information Technology of the People's Republic of China, Nanjing Nuoerman Biotechnology Co., Ltd. was included in the fourth batch of "National SRDI Little Giants" enterprises, and recently officially gave the plaque to the company, valid from July 1, 2022 to June 30, 2025.

"National SRDILittle Giants" (specialized, refinement, differential, innovation)enterprise is selected through the procedures of provincial competent department recommendation, expert review and public announcement, focusing on market segments, strong innovation ability, high market share, mastering core key technologies. A vanguard enterprise with excellent quality and benefit.

Norman has been identified as "National SRDILittle Giants"enterprise, which reflects that the company has been fully recognized and highly affirmed by relevant government departments in terms of technology, product services and future development prospects, and will help enhance the company's brand awareness and market competitiveness, which will have a positive effect on the company's future development. In the future, Norman will continue to improve its independent innovation capabilities, continue to increase investment in research and development, adhere to the road of technological specialization, specialization and innovation, and provide more complete and richer solutions for human health.